Two Labs, an Envision Pharma Group company Acquires Riparian

Two Labs, an Envision Pharma Group Company, Acquires Riparian

The partnership expands Two Labs’ suite of services and broadens its integration competency to include government price reporting

COLUMBUS, Ohio (7/7/2021) — Two Labs, an industry-leading pharma services company and part of Envision Pharma Group, today announced that it has … ...

US Value-Based Management of Oncology Drugs

US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs

Oncology and other specialty therapies continue to get more and more expensive for payers, placing immense financial pressure on the HCP. The percentage increase in worldwide spending on oncology medications went up by double digits every year between 2013 and … ...

Two Labs Medical Affairs Best Practices Featured in PharmExec

Two Labs Medical Affairs Best Practices Featured in PharmExec

Globalizing Medical Affairs can often pull teams away from focusing on their local needs. Our Medical Affairs solution identifies challenges that impede globalization efforts and recommends tactics for optimizing both local and global operations. A one-size-fits-all approach is not sufficient … ...

Two Labs State Licensing Strategy Featured in PM360

Two Labs State Licensing Strategy Featured in PM360

State licensing is one of the most difficult, unpredictable aspects of launching a new drug. Two Labs insulates your company from costly pitfalls that can easily derail your launch, while ensuring that you’re in the know about how to remain … ...

We’re here to support your success from clinical to commercial – and beyond.

How can we help you today?